mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
AP

Ajanta Pharma Limited

NSE:AJANTPHARMBSE:AJANTPHARM
HealthcarePharmaceuticals & BiotechnologyNIFTY MIDCAP 150 +4
₹3,581.0
-1.1%1 Oct close
Mkt cap
₹44,727 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
QuarterlyAnnual

Year ends (Mar) · % of equity

Holder (%)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
70.48%66.11%66.21%66.26%66.25%
0%10%8.54%8.86%8.26%
0%15.98%17.49%17.48%18.37%
0%0%0%0%0.01%
29.52%7.91%7.76%7.4%7.11%
No. of shareholders————67,955

Promoter holding down 7 percentage points since Mar 2022. One column per financial year, taken from the register filed at that year end.

74 deals · 20 Dec 2021 – 9 Jun 2026
DateClientTypeVenueSideQuantityPriceValue
9 Jun 2026RAVI AGRAWAL TRUSTBlockNSESell34,50,000₹2,968.00₹1,023.96 Cr
9 Jun 2026RAVI AGRAWAL TRUSTBulkNSESell34,50,000₹2,968.00₹1,023.96 Cr
9 Jun 2026KOTAK MAHINDRA MUTUAL FUNDBlockNSEBuy21,02,291₹2,968.00₹623.96 Cr
9 Jun 2026KOTAK MAHINDRA MUTUAL FUNDBulkNSEBuy21,02,291₹2,968.00₹623.96 Cr
9 Jun 2026ADITYA BIRLA SUN LIFE MUTUAL FUNDBlockNSEBuy13,47,709₹2,968.00₹400.00 Cr
25 Jan 2024SOCIETE GENERALEBlockBSEBuy1,25,617₹2,195.50₹27.58 Cr
25 Jan 2024BNP PARIBAS ARBITRAGEBlockBSESell1,25,617₹2,195.50₹27.58 Cr
25 Jan 2024BNP PARIBAS ARBITRAGEBlockBSESell50,586₹2,195.50₹11.11 Cr
25 Jan 2024MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUNDBlockBSEBuy47,901₹2,195.50₹10.52 Cr
25 Jan 2024MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUNDBlockBSEBuy2,685₹2,195.50₹0.59 Cr
1–10 of 74
1 / 8

  • Mr. Mannalal B. AgrawalNon-Executive - Non Independent Director-Chairperson related to Promoter
  • Arvind K AgrawalChief Financial Officer
  • Mr. Madhusudan B. AgrawalExecutive Director
  • Mr. Yogesh Mannalal AgrawalExecutive Director-MD
  • Mr. Rajesh Mannalal AgrawalExecutive Director
  • Mr. David RasquinhaNon-Executive - Independent Director
  • Ms. Medha Vinay JoshiNon-Executive - Independent Director
  • Mr. Rajesh Shashikant DalalNon-Executive - Independent Director
  • Ms. Simi Manohar Lal ThaparNon-Executive - Independent Director
  • Gaurang ShahCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.